In order to achieve testing and validation of Titan’s Insertable Robotic Effector Platform (IREP), the company recently declared that it has entered into a research agreement with Vanderbilt University along with the Advanced Robotics and Mechanism Applications Research Laboratory (ARMA lab).
This initiative is headed by the associate professor of mechanical engineering Dr. Nabil Simaan, who is associated with Vanderbilt University’s recently developed Vanderbilt Initiative in Surgery and Engineering (VISE).
As per the agreement, IREP will be tested by the ARMA lab where engineering, exploratory, workspace, and tissue testing will be conducted over a period of eight weeks. The IREP’s assessment and evaluation will represent the need for further upgrades and clinical plans in order to achieve commercialization and regulatory submission of the IREP.
Titan Medical’s CEO Craig Leon said that IREP’s advancement will contribute to the company’s mission to supply advanced robotic surgical solutions for an entire range of global hospitals. The company anticipates progressing with the IREP’s clinical development. This advancement will present the healthcare units with innovative and advanced robotic surgery solution enabling single port access surgery.
Based in Canada, Titan Medical develops and commercializes robotic surgical technologies. At present, Titan is developing a new surgical system called Amadeus Composer that encompasses special external robot and flexible instruments. This innovative surgical system will serve as an excellent medical tool for surgeons to perform surgical procedures in a very effective and simplified way.